Drug regulator declares Combiflam, D-cold Total substandard

New Delhi : The Central Drugs Standard Control Organization (CDSCO) that regulates the sales and distribution for drugs in India has declared these two popular Combiflam and D-Cold Total medicines as substandard.

Combiflam is manufactured by Sanofi India while D-Cold Total is made by Reckitt Benckiser Healthcare India.

The CDSCO conducted tests last month and, in addition to the two drugs mentioned above, found Cipla's Oflox-100 DT tablets and Theo Asthalin tablets, and Cadila's Cadilose solution to be substandard as well.

Oflox-100 DT is an antibiotic while Theo Asthalin is used for respiratory issues. Cadilose is usually prescribed for constipation.

In total, the CDSCO has issued a drug alert for 60 medicines, including five aforementioned drugs, as they failed different quality tests in March 2017, the Indian Express noted.

 

Combiflam manufacturer Sanofi has assured appropriate action once it receives official notice from the drug regulator.